Covid-19 Impact on Global Opioid Use Disorder Market Size, Status and Forecast 2020-2026
An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress.
Increase in opioid epidemic in the U.S. coupled with establishment of government policies to control the crisis is driving the market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Opioid Use Disorder market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Opioid Use Disorder industry.
Based on our recent survey, we have several different scenarios about the Opioid Use Disorder YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 1696.7 million in 2019. The market size of Opioid Use Disorder will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Opioid Use Disorder market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Opioid Use Disorder market in terms of revenue.
Players, stakeholders, and other participants in the global Opioid Use Disorder market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Opioid Use Disorder market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Opioid Use Disorder market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Opioid Use Disorder market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Opioid Use Disorder market.
The following players are covered in this report:
Increase in opioid epidemic in the U.S. coupled with establishment of government policies to control the crisis is driving the market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Opioid Use Disorder market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Opioid Use Disorder industry.
Based on our recent survey, we have several different scenarios about the Opioid Use Disorder YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 1696.7 million in 2019. The market size of Opioid Use Disorder will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Opioid Use Disorder market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Opioid Use Disorder market in terms of revenue.
Players, stakeholders, and other participants in the global Opioid Use Disorder market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Opioid Use Disorder market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Opioid Use Disorder market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Opioid Use Disorder market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Opioid Use Disorder market.
The following players are covered in this report:
- Indivior
- Alkermes
- Titan Pharmaceuticals
- Hikma Pharmaceuticals
- Teva Pharmaceuticals
- MediciNova
- Orexo
- Camurus
- Omeros
- Buprenorphine
- Methadone
- Naltrexone
- Moderate Pain Treatment
- Severe Pain Treatment
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Opioid Use Disorder Revenue
1.4 Market Analysis by Type
1.4.1 Global Opioid Use Disorder Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Buprenorphine
1.4.3 Methadone
1.4.4 Naltrexone
1.5 Market by Application
1.5.1 Global Opioid Use Disorder Market Share by Application: 2020 VS 2026
1.5.2 Moderate Pain Treatment
1.5.3 Severe Pain Treatment
1.6 Coronavirus Disease 2019 (Covid-19): Opioid Use Disorder Industry Impact
1.6.1 How the Covid-19 is Affecting the Opioid Use Disorder Industry
1.6.1.1 Opioid Use Disorder Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Opioid Use Disorder Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Opioid Use Disorder Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Opioid Use Disorder Market Perspective (2015-2026)
2.2 Opioid Use Disorder Growth Trends by Regions
2.2.1 Opioid Use Disorder Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Opioid Use Disorder Historic Market Share by Regions (2015-2020)
2.2.3 Opioid Use Disorder Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Opioid Use Disorder Market Growth Strategy
2.3.6 Primary Interviews with Key Opioid Use Disorder Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Opioid Use Disorder Players by Market Size
3.1.1 Global Top Opioid Use Disorder Players by Revenue (2015-2020)
3.1.2 Global Opioid Use Disorder Revenue Market Share by Players (2015-2020)
3.1.3 Global Opioid Use Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Opioid Use Disorder Market Concentration Ratio
3.2.1 Global Opioid Use Disorder Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Opioid Use Disorder Revenue in 2019
3.3 Opioid Use Disorder Key Players Head office and Area Served
3.4 Key Players Opioid Use Disorder Product Solution and Service
3.5 Date of Enter into Opioid Use Disorder Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Opioid Use Disorder Historic Market Size by Type (2015-2020)
4.2 Global Opioid Use Disorder Forecasted Market Size by Type (2021-2026)
5 OPIOID USE DISORDER BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Opioid Use Disorder Market Size by Application (2015-2020)
5.2 Global Opioid Use Disorder Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Opioid Use Disorder Market Size (2015-2020)
6.2 Opioid Use Disorder Key Players in North America (2019-2020)
6.3 North America Opioid Use Disorder Market Size by Type (2015-2020)
6.4 North America Opioid Use Disorder Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Opioid Use Disorder Market Size (2015-2020)
7.2 Opioid Use Disorder Key Players in Europe (2019-2020)
7.3 Europe Opioid Use Disorder Market Size by Type (2015-2020)
7.4 Europe Opioid Use Disorder Market Size by Application (2015-2020)
8 CHINA
8.1 China Opioid Use Disorder Market Size (2015-2020)
8.2 Opioid Use Disorder Key Players in China (2019-2020)
8.3 China Opioid Use Disorder Market Size by Type (2015-2020)
8.4 China Opioid Use Disorder Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Opioid Use Disorder Market Size (2015-2020)
9.2 Opioid Use Disorder Key Players in Japan (2019-2020)
9.3 Japan Opioid Use Disorder Market Size by Type (2015-2020)
9.4 Japan Opioid Use Disorder Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Opioid Use Disorder Market Size (2015-2020)
10.2 Opioid Use Disorder Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Opioid Use Disorder Market Size by Type (2015-2020)
10.4 Southeast Asia Opioid Use Disorder Market Size by Application (2015-2020)
11 INDIA
11.1 India Opioid Use Disorder Market Size (2015-2020)
11.2 Opioid Use Disorder Key Players in India (2019-2020)
11.3 India Opioid Use Disorder Market Size by Type (2015-2020)
11.4 India Opioid Use Disorder Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Opioid Use Disorder Market Size (2015-2020)
12.2 Opioid Use Disorder Key Players in Central & South America (2019-2020)
12.3 Central & South America Opioid Use Disorder Market Size by Type (2015-2020)
12.4 Central & South America Opioid Use Disorder Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Indivior
13.1.1 Indivior Company Details
13.1.2 Indivior Business Overview and Its Total Revenue
13.1.3 Indivior Opioid Use Disorder Introduction
13.1.4 Indivior Revenue in Opioid Use Disorder Business (2015-2020))
13.1.5 Indivior Recent Development
13.2 Alkermes
13.2.1 Alkermes Company Details
13.2.2 Alkermes Business Overview and Its Total Revenue
13.2.3 Alkermes Opioid Use Disorder Introduction
13.2.4 Alkermes Revenue in Opioid Use Disorder Business (2015-2020)
13.2.5 Alkermes Recent Development
13.3 Titan Pharmaceuticals
13.3.1 Titan Pharmaceuticals Company Details
13.3.2 Titan Pharmaceuticals Business Overview and Its Total Revenue
13.3.3 Titan Pharmaceuticals Opioid Use Disorder Introduction
13.3.4 Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2015-2020)
13.3.5 Titan Pharmaceuticals Recent Development
13.4 Hikma Pharmaceuticals
13.4.1 Hikma Pharmaceuticals Company Details
13.4.2 Hikma Pharmaceuticals Business Overview and Its Total Revenue
13.4.3 Hikma Pharmaceuticals Opioid Use Disorder Introduction
13.4.4 Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2015-2020)
13.4.5 Hikma Pharmaceuticals Recent Development
13.5 Teva Pharmaceuticals
13.5.1 Teva Pharmaceuticals Company Details
13.5.2 Teva Pharmaceuticals Business Overview and Its Total Revenue
13.5.3 Teva Pharmaceuticals Opioid Use Disorder Introduction
13.5.4 Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2015-2020)
13.5.5 Teva Pharmaceuticals Recent Development
13.6 MediciNova
13.6.1 MediciNova Company Details
13.6.2 MediciNova Business Overview and Its Total Revenue
13.6.3 MediciNova Opioid Use Disorder Introduction
13.6.4 MediciNova Revenue in Opioid Use Disorder Business (2015-2020)
13.6.5 MediciNova Recent Development
13.7 Orexo
13.7.1 Orexo Company Details
13.7.2 Orexo Business Overview and Its Total Revenue
13.7.3 Orexo Opioid Use Disorder Introduction
13.7.4 Orexo Revenue in Opioid Use Disorder Business (2015-2020)
13.7.5 Orexo Recent Development
13.8 Camurus
13.8.1 Camurus Company Details
13.8.2 Camurus Business Overview and Its Total Revenue
13.8.3 Camurus Opioid Use Disorder Introduction
13.8.4 Camurus Revenue in Opioid Use Disorder Business (2015-2020)
13.8.5 Camurus Recent Development
13.9 Omeros
13.9.1 Omeros Company Details
13.9.2 Omeros Business Overview and Its Total Revenue
13.9.3 Omeros Opioid Use Disorder Introduction
13.9.4 Omeros Revenue in Opioid Use Disorder Business (2015-2020)
13.9.5 Omeros Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Opioid Use Disorder Revenue
1.4 Market Analysis by Type
1.4.1 Global Opioid Use Disorder Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Buprenorphine
1.4.3 Methadone
1.4.4 Naltrexone
1.5 Market by Application
1.5.1 Global Opioid Use Disorder Market Share by Application: 2020 VS 2026
1.5.2 Moderate Pain Treatment
1.5.3 Severe Pain Treatment
1.6 Coronavirus Disease 2019 (Covid-19): Opioid Use Disorder Industry Impact
1.6.1 How the Covid-19 is Affecting the Opioid Use Disorder Industry
1.6.1.1 Opioid Use Disorder Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Opioid Use Disorder Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Opioid Use Disorder Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Opioid Use Disorder Market Perspective (2015-2026)
2.2 Opioid Use Disorder Growth Trends by Regions
2.2.1 Opioid Use Disorder Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Opioid Use Disorder Historic Market Share by Regions (2015-2020)
2.2.3 Opioid Use Disorder Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Opioid Use Disorder Market Growth Strategy
2.3.6 Primary Interviews with Key Opioid Use Disorder Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Opioid Use Disorder Players by Market Size
3.1.1 Global Top Opioid Use Disorder Players by Revenue (2015-2020)
3.1.2 Global Opioid Use Disorder Revenue Market Share by Players (2015-2020)
3.1.3 Global Opioid Use Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Opioid Use Disorder Market Concentration Ratio
3.2.1 Global Opioid Use Disorder Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Opioid Use Disorder Revenue in 2019
3.3 Opioid Use Disorder Key Players Head office and Area Served
3.4 Key Players Opioid Use Disorder Product Solution and Service
3.5 Date of Enter into Opioid Use Disorder Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Opioid Use Disorder Historic Market Size by Type (2015-2020)
4.2 Global Opioid Use Disorder Forecasted Market Size by Type (2021-2026)
5 OPIOID USE DISORDER BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Opioid Use Disorder Market Size by Application (2015-2020)
5.2 Global Opioid Use Disorder Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Opioid Use Disorder Market Size (2015-2020)
6.2 Opioid Use Disorder Key Players in North America (2019-2020)
6.3 North America Opioid Use Disorder Market Size by Type (2015-2020)
6.4 North America Opioid Use Disorder Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Opioid Use Disorder Market Size (2015-2020)
7.2 Opioid Use Disorder Key Players in Europe (2019-2020)
7.3 Europe Opioid Use Disorder Market Size by Type (2015-2020)
7.4 Europe Opioid Use Disorder Market Size by Application (2015-2020)
8 CHINA
8.1 China Opioid Use Disorder Market Size (2015-2020)
8.2 Opioid Use Disorder Key Players in China (2019-2020)
8.3 China Opioid Use Disorder Market Size by Type (2015-2020)
8.4 China Opioid Use Disorder Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Opioid Use Disorder Market Size (2015-2020)
9.2 Opioid Use Disorder Key Players in Japan (2019-2020)
9.3 Japan Opioid Use Disorder Market Size by Type (2015-2020)
9.4 Japan Opioid Use Disorder Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Opioid Use Disorder Market Size (2015-2020)
10.2 Opioid Use Disorder Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Opioid Use Disorder Market Size by Type (2015-2020)
10.4 Southeast Asia Opioid Use Disorder Market Size by Application (2015-2020)
11 INDIA
11.1 India Opioid Use Disorder Market Size (2015-2020)
11.2 Opioid Use Disorder Key Players in India (2019-2020)
11.3 India Opioid Use Disorder Market Size by Type (2015-2020)
11.4 India Opioid Use Disorder Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Opioid Use Disorder Market Size (2015-2020)
12.2 Opioid Use Disorder Key Players in Central & South America (2019-2020)
12.3 Central & South America Opioid Use Disorder Market Size by Type (2015-2020)
12.4 Central & South America Opioid Use Disorder Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Indivior
13.1.1 Indivior Company Details
13.1.2 Indivior Business Overview and Its Total Revenue
13.1.3 Indivior Opioid Use Disorder Introduction
13.1.4 Indivior Revenue in Opioid Use Disorder Business (2015-2020))
13.1.5 Indivior Recent Development
13.2 Alkermes
13.2.1 Alkermes Company Details
13.2.2 Alkermes Business Overview and Its Total Revenue
13.2.3 Alkermes Opioid Use Disorder Introduction
13.2.4 Alkermes Revenue in Opioid Use Disorder Business (2015-2020)
13.2.5 Alkermes Recent Development
13.3 Titan Pharmaceuticals
13.3.1 Titan Pharmaceuticals Company Details
13.3.2 Titan Pharmaceuticals Business Overview and Its Total Revenue
13.3.3 Titan Pharmaceuticals Opioid Use Disorder Introduction
13.3.4 Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2015-2020)
13.3.5 Titan Pharmaceuticals Recent Development
13.4 Hikma Pharmaceuticals
13.4.1 Hikma Pharmaceuticals Company Details
13.4.2 Hikma Pharmaceuticals Business Overview and Its Total Revenue
13.4.3 Hikma Pharmaceuticals Opioid Use Disorder Introduction
13.4.4 Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2015-2020)
13.4.5 Hikma Pharmaceuticals Recent Development
13.5 Teva Pharmaceuticals
13.5.1 Teva Pharmaceuticals Company Details
13.5.2 Teva Pharmaceuticals Business Overview and Its Total Revenue
13.5.3 Teva Pharmaceuticals Opioid Use Disorder Introduction
13.5.4 Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2015-2020)
13.5.5 Teva Pharmaceuticals Recent Development
13.6 MediciNova
13.6.1 MediciNova Company Details
13.6.2 MediciNova Business Overview and Its Total Revenue
13.6.3 MediciNova Opioid Use Disorder Introduction
13.6.4 MediciNova Revenue in Opioid Use Disorder Business (2015-2020)
13.6.5 MediciNova Recent Development
13.7 Orexo
13.7.1 Orexo Company Details
13.7.2 Orexo Business Overview and Its Total Revenue
13.7.3 Orexo Opioid Use Disorder Introduction
13.7.4 Orexo Revenue in Opioid Use Disorder Business (2015-2020)
13.7.5 Orexo Recent Development
13.8 Camurus
13.8.1 Camurus Company Details
13.8.2 Camurus Business Overview and Its Total Revenue
13.8.3 Camurus Opioid Use Disorder Introduction
13.8.4 Camurus Revenue in Opioid Use Disorder Business (2015-2020)
13.8.5 Camurus Recent Development
13.9 Omeros
13.9.1 Omeros Company Details
13.9.2 Omeros Business Overview and Its Total Revenue
13.9.3 Omeros Opioid Use Disorder Introduction
13.9.4 Omeros Revenue in Opioid Use Disorder Business (2015-2020)
13.9.5 Omeros Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Opioid Use Disorder Key Market Segments
Table 2. Key Players Covered: Ranking by Opioid Use Disorder Revenue
Table 3. Ranking of Global Top Opioid Use Disorder Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Opioid Use Disorder Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Buprenorphine
Table 6. Key Players of Methadone
Table 7. Key Players of Naltrexone
Table 8. COVID-19 Impact Global Market: (Four Opioid Use Disorder Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Opioid Use Disorder Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Opioid Use Disorder Players to Combat Covid-19 Impact
Table 13. Global Opioid Use Disorder Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Opioid Use Disorder Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Opioid Use Disorder Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Opioid Use Disorder Market Share by Regions (2015-2020)
Table 17. Global Opioid Use Disorder Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Opioid Use Disorder Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Opioid Use Disorder Market Growth Strategy
Table 23. Main Points Interviewed from Key Opioid Use Disorder Players
Table 24. Global Opioid Use Disorder Revenue by Players (2015-2020) (Million US$)
Table 25. Global Opioid Use Disorder Market Share by Players (2015-2020)
Table 26. Global Top Opioid Use Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Use Disorder as of 2019)
Table 27. Global Opioid Use Disorder by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Opioid Use Disorder Product Solution and Service
Table 30. Date of Enter into Opioid Use Disorder Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Opioid Use Disorder Market Size by Type (2015-2020) (Million US$)
Table 33. Global Opioid Use Disorder Market Size Share by Type (2015-2020)
Table 34. Global Opioid Use Disorder Revenue Market Share by Type (2021-2026)
Table 35. Global Opioid Use Disorder Market Size Share by Application (2015-2020)
Table 36. Global Opioid Use Disorder Market Size by Application (2015-2020) (Million US$)
Table 37. Global Opioid Use Disorder Market Size Share by Application (2021-2026)
Table 38. North America Key Players Opioid Use Disorder Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Opioid Use Disorder Market Share (2019-2020)
Table 40. North America Opioid Use Disorder Market Size by Type (2015-2020) (Million US$)
Table 41. North America Opioid Use Disorder Market Share by Type (2015-2020)
Table 42. North America Opioid Use Disorder Market Size by Application (2015-2020) (Million US$)
Table 43. North America Opioid Use Disorder Market Share by Application (2015-2020)
Table 44. Europe Key Players Opioid Use Disorder Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Opioid Use Disorder Market Share (2019-2020)
Table 46. Europe Opioid Use Disorder Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Opioid Use Disorder Market Share by Type (2015-2020)
Table 48. Europe Opioid Use Disorder Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Opioid Use Disorder Market Share by Application (2015-2020)
Table 50. China Key Players Opioid Use Disorder Revenue (2019-2020) (Million US$)
Table 51. China Key Players Opioid Use Disorder Market Share (2019-2020)
Table 52. China Opioid Use Disorder Market Size by Type (2015-2020) (Million US$)
Table 53. China Opioid Use Disorder Market Share by Type (2015-2020)
Table 54. China Opioid Use Disorder Market Size by Application (2015-2020) (Million US$)
Table 55. China Opioid Use Disorder Market Share by Application (2015-2020)
Table 56. Japan Key Players Opioid Use Disorder Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Opioid Use Disorder Market Share (2019-2020)
Table 58. Japan Opioid Use Disorder Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Opioid Use Disorder Market Share by Type (2015-2020)
Table 60. Japan Opioid Use Disorder Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Opioid Use Disorder Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Opioid Use Disorder Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Opioid Use Disorder Market Share (2019-2020)
Table 64. Southeast Asia Opioid Use Disorder Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Opioid Use Disorder Market Share by Type (2015-2020)
Table 66. Southeast Asia Opioid Use Disorder Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Opioid Use Disorder Market Share by Application (2015-2020)
Table 68. India Key Players Opioid Use Disorder Revenue (2019-2020) (Million US$)
Table 69. India Key Players Opioid Use Disorder Market Share (2019-2020)
Table 70. India Opioid Use Disorder Market Size by Type (2015-2020) (Million US$)
Table 71. India Opioid Use Disorder Market Share by Type (2015-2020)
Table 72. India Opioid Use Disorder Market Size by Application (2015-2020) (Million US$)
Table 73. India Opioid Use Disorder Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Opioid Use Disorder Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Opioid Use Disorder Market Share (2019-2020)
Table 76. Central & South America Opioid Use Disorder Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Opioid Use Disorder Market Share by Type (2015-2020)
Table 78. Central & South America Opioid Use Disorder Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Opioid Use Disorder Market Share by Application (2015-2020)
Table 80. Indivior Company Details
Table 81. Indivior Business Overview
Table 82. Indivior Product
Table 83. Indivior Revenue in Opioid Use Disorder Business (2015-2020) (Million US$)
Table 84. Indivior Recent Development
Table 85. Alkermes Company Details
Table 86. Alkermes Business Overview
Table 87. Alkermes Product
Table 88. Alkermes Revenue in Opioid Use Disorder Business (2015-2020) (Million US$)
Table 89. Alkermes Recent Development
Table 90. Titan Pharmaceuticals Company Details
Table 91. Titan Pharmaceuticals Business Overview
Table 92. Titan Pharmaceuticals Product
Table 93. Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2015-2020) (Million US$)
Table 94. Titan Pharmaceuticals Recent Development
Table 95. Hikma Pharmaceuticals Company Details
Table 96. Hikma Pharmaceuticals Business Overview
Table 97. Hikma Pharmaceuticals Product
Table 98. Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2015-2020) (Million US$)
Table 99. Hikma Pharmaceuticals Recent Development
Table 100. Teva Pharmaceuticals Company Details
Table 101. Teva Pharmaceuticals Business Overview
Table 102. Teva Pharmaceuticals Product
Table 103. Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2015-2020) (Million US$)
Table 104. Teva Pharmaceuticals Recent Development
Table 105. MediciNova Company Details
Table 106. MediciNova Business Overview
Table 107. MediciNova Product
Table 108. MediciNova Revenue in Opioid Use Disorder Business (2015-2020) (Million US$)
Table 109. MediciNova Recent Development
Table 110. Orexo Company Details
Table 111. Orexo Business Overview
Table 112. Orexo Product
Table 113. Orexo Revenue in Opioid Use Disorder Business (2015-2020) (Million US$)
Table 114. Orexo Recent Development
Table 115. Camurus Business Overview
Table 116. Camurus Product
Table 117. Camurus Company Details
Table 118. Camurus Revenue in Opioid Use Disorder Business (2015-2020) (Million US$)
Table 119. Camurus Recent Development
Table 120. Omeros Company Details
Table 121. Omeros Business Overview
Table 122. Omeros Product
Table 123. Omeros Revenue in Opioid Use Disorder Business (2015-2020) (Million US$)
Table 124. Omeros Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 1. Opioid Use Disorder Key Market Segments
Table 2. Key Players Covered: Ranking by Opioid Use Disorder Revenue
Table 3. Ranking of Global Top Opioid Use Disorder Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Opioid Use Disorder Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Buprenorphine
Table 6. Key Players of Methadone
Table 7. Key Players of Naltrexone
Table 8. COVID-19 Impact Global Market: (Four Opioid Use Disorder Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Opioid Use Disorder Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Opioid Use Disorder Players to Combat Covid-19 Impact
Table 13. Global Opioid Use Disorder Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Opioid Use Disorder Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Opioid Use Disorder Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Opioid Use Disorder Market Share by Regions (2015-2020)
Table 17. Global Opioid Use Disorder Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Opioid Use Disorder Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Opioid Use Disorder Market Growth Strategy
Table 23. Main Points Interviewed from Key Opioid Use Disorder Players
Table 24. Global Opioid Use Disorder Revenue by Players (2015-2020) (Million US$)
Table 25. Global Opioid Use Disorder Market Share by Players (2015-2020)
Table 26. Global Top Opioid Use Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Use Disorder as of 2019)
Table 27. Global Opioid Use Disorder by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Opioid Use Disorder Product Solution and Service
Table 30. Date of Enter into Opioid Use Disorder Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Opioid Use Disorder Market Size by Type (2015-2020) (Million US$)
Table 33. Global Opioid Use Disorder Market Size Share by Type (2015-2020)
Table 34. Global Opioid Use Disorder Revenue Market Share by Type (2021-2026)
Table 35. Global Opioid Use Disorder Market Size Share by Application (2015-2020)
Table 36. Global Opioid Use Disorder Market Size by Application (2015-2020) (Million US$)
Table 37. Global Opioid Use Disorder Market Size Share by Application (2021-2026)
Table 38. North America Key Players Opioid Use Disorder Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Opioid Use Disorder Market Share (2019-2020)
Table 40. North America Opioid Use Disorder Market Size by Type (2015-2020) (Million US$)
Table 41. North America Opioid Use Disorder Market Share by Type (2015-2020)
Table 42. North America Opioid Use Disorder Market Size by Application (2015-2020) (Million US$)
Table 43. North America Opioid Use Disorder Market Share by Application (2015-2020)
Table 44. Europe Key Players Opioid Use Disorder Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Opioid Use Disorder Market Share (2019-2020)
Table 46. Europe Opioid Use Disorder Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Opioid Use Disorder Market Share by Type (2015-2020)
Table 48. Europe Opioid Use Disorder Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Opioid Use Disorder Market Share by Application (2015-2020)
Table 50. China Key Players Opioid Use Disorder Revenue (2019-2020) (Million US$)
Table 51. China Key Players Opioid Use Disorder Market Share (2019-2020)
Table 52. China Opioid Use Disorder Market Size by Type (2015-2020) (Million US$)
Table 53. China Opioid Use Disorder Market Share by Type (2015-2020)
Table 54. China Opioid Use Disorder Market Size by Application (2015-2020) (Million US$)
Table 55. China Opioid Use Disorder Market Share by Application (2015-2020)
Table 56. Japan Key Players Opioid Use Disorder Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Opioid Use Disorder Market Share (2019-2020)
Table 58. Japan Opioid Use Disorder Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Opioid Use Disorder Market Share by Type (2015-2020)
Table 60. Japan Opioid Use Disorder Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Opioid Use Disorder Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Opioid Use Disorder Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Opioid Use Disorder Market Share (2019-2020)
Table 64. Southeast Asia Opioid Use Disorder Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Opioid Use Disorder Market Share by Type (2015-2020)
Table 66. Southeast Asia Opioid Use Disorder Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Opioid Use Disorder Market Share by Application (2015-2020)
Table 68. India Key Players Opioid Use Disorder Revenue (2019-2020) (Million US$)
Table 69. India Key Players Opioid Use Disorder Market Share (2019-2020)
Table 70. India Opioid Use Disorder Market Size by Type (2015-2020) (Million US$)
Table 71. India Opioid Use Disorder Market Share by Type (2015-2020)
Table 72. India Opioid Use Disorder Market Size by Application (2015-2020) (Million US$)
Table 73. India Opioid Use Disorder Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Opioid Use Disorder Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Opioid Use Disorder Market Share (2019-2020)
Table 76. Central & South America Opioid Use Disorder Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Opioid Use Disorder Market Share by Type (2015-2020)
Table 78. Central & South America Opioid Use Disorder Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Opioid Use Disorder Market Share by Application (2015-2020)
Table 80. Indivior Company Details
Table 81. Indivior Business Overview
Table 82. Indivior Product
Table 83. Indivior Revenue in Opioid Use Disorder Business (2015-2020) (Million US$)
Table 84. Indivior Recent Development
Table 85. Alkermes Company Details
Table 86. Alkermes Business Overview
Table 87. Alkermes Product
Table 88. Alkermes Revenue in Opioid Use Disorder Business (2015-2020) (Million US$)
Table 89. Alkermes Recent Development
Table 90. Titan Pharmaceuticals Company Details
Table 91. Titan Pharmaceuticals Business Overview
Table 92. Titan Pharmaceuticals Product
Table 93. Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2015-2020) (Million US$)
Table 94. Titan Pharmaceuticals Recent Development
Table 95. Hikma Pharmaceuticals Company Details
Table 96. Hikma Pharmaceuticals Business Overview
Table 97. Hikma Pharmaceuticals Product
Table 98. Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2015-2020) (Million US$)
Table 99. Hikma Pharmaceuticals Recent Development
Table 100. Teva Pharmaceuticals Company Details
Table 101. Teva Pharmaceuticals Business Overview
Table 102. Teva Pharmaceuticals Product
Table 103. Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2015-2020) (Million US$)
Table 104. Teva Pharmaceuticals Recent Development
Table 105. MediciNova Company Details
Table 106. MediciNova Business Overview
Table 107. MediciNova Product
Table 108. MediciNova Revenue in Opioid Use Disorder Business (2015-2020) (Million US$)
Table 109. MediciNova Recent Development
Table 110. Orexo Company Details
Table 111. Orexo Business Overview
Table 112. Orexo Product
Table 113. Orexo Revenue in Opioid Use Disorder Business (2015-2020) (Million US$)
Table 114. Orexo Recent Development
Table 115. Camurus Business Overview
Table 116. Camurus Product
Table 117. Camurus Company Details
Table 118. Camurus Revenue in Opioid Use Disorder Business (2015-2020) (Million US$)
Table 119. Camurus Recent Development
Table 120. Omeros Company Details
Table 121. Omeros Business Overview
Table 122. Omeros Product
Table 123. Omeros Revenue in Opioid Use Disorder Business (2015-2020) (Million US$)
Table 124. Omeros Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Opioid Use Disorder Market Share by Type: 2020 VS 2026
Figure 2. Buprenorphine Features
Figure 3. Methadone Features
Figure 4. Naltrexone Features
Figure 5. Global Opioid Use Disorder Market Share by Application: 2020 VS 2026
Figure 6. Moderate Pain Treatment Case Studies
Figure 7. Severe Pain Treatment Case Studies
Figure 8. Opioid Use Disorder Report Years Considered
Figure 9. Global Opioid Use Disorder Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Opioid Use Disorder Market Share by Regions: 2020 VS 2026
Figure 11. Global Opioid Use Disorder Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Opioid Use Disorder Market Share by Players in 2019
Figure 14. Global Top Opioid Use Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Use Disorder as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Opioid Use Disorder Revenue in 2019
Figure 16. North America Opioid Use Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Opioid Use Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Opioid Use Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Opioid Use Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Opioid Use Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Opioid Use Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Opioid Use Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Indivior Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Indivior Revenue Growth Rate in Opioid Use Disorder Business (2015-2020)
Figure 25. Alkermes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Alkermes Revenue Growth Rate in Opioid Use Disorder Business (2015-2020)
Figure 27. Titan Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Titan Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2015-2020)
Figure 29. Hikma Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Hikma Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2015-2020)
Figure 31. Teva Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Teva Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2015-2020)
Figure 33. MediciNova Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. MediciNova Revenue Growth Rate in Opioid Use Disorder Business (2015-2020)
Figure 35. Orexo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Orexo Revenue Growth Rate in Opioid Use Disorder Business (2015-2020)
Figure 37. Camurus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Camurus Revenue Growth Rate in Opioid Use Disorder Business (2015-2020)
Figure 39. Omeros Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Omeros Revenue Growth Rate in Opioid Use Disorder Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
Figure 1. Global Opioid Use Disorder Market Share by Type: 2020 VS 2026
Figure 2. Buprenorphine Features
Figure 3. Methadone Features
Figure 4. Naltrexone Features
Figure 5. Global Opioid Use Disorder Market Share by Application: 2020 VS 2026
Figure 6. Moderate Pain Treatment Case Studies
Figure 7. Severe Pain Treatment Case Studies
Figure 8. Opioid Use Disorder Report Years Considered
Figure 9. Global Opioid Use Disorder Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Opioid Use Disorder Market Share by Regions: 2020 VS 2026
Figure 11. Global Opioid Use Disorder Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Opioid Use Disorder Market Share by Players in 2019
Figure 14. Global Top Opioid Use Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Use Disorder as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Opioid Use Disorder Revenue in 2019
Figure 16. North America Opioid Use Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Opioid Use Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Opioid Use Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Opioid Use Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Opioid Use Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Opioid Use Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Opioid Use Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Indivior Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Indivior Revenue Growth Rate in Opioid Use Disorder Business (2015-2020)
Figure 25. Alkermes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Alkermes Revenue Growth Rate in Opioid Use Disorder Business (2015-2020)
Figure 27. Titan Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Titan Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2015-2020)
Figure 29. Hikma Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Hikma Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2015-2020)
Figure 31. Teva Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Teva Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2015-2020)
Figure 33. MediciNova Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. MediciNova Revenue Growth Rate in Opioid Use Disorder Business (2015-2020)
Figure 35. Orexo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Orexo Revenue Growth Rate in Opioid Use Disorder Business (2015-2020)
Figure 37. Camurus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Camurus Revenue Growth Rate in Opioid Use Disorder Business (2015-2020)
Figure 39. Omeros Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Omeros Revenue Growth Rate in Opioid Use Disorder Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
